Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway

E-ISSN： 1349-7006|106|10|1341-1350

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.10, 2015-10, pp. : 1341-1350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ginkgetin inhibits the growth of DU−145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 413-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

CRKL oncogene is downregulated by p53 through miR‐200s

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 1033-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1596-1606

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1750-1760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1223-1232

John Wiley & Sons Inc

Access to resources Recommend Favorite